1. 'Train‐the‐Trainer': an effective and successful model to accelerate training and improve physiotherapy services for persons with haemophilia in China. (20th November 2013) Authors: Chen, L.; Sun, J.; Hilliard, P.; Zourikian, N.; Hang, M.; Blanchette, V.; Poon, M.‐C.; Luke, K. Journal: Haemophilia Issue: Volume 20:Number 3(2014:May) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 009 The Fertility Quality of Life (FertiQol) in Chinese Infertile Women: The First Validation Study of Mainland China Ferti-Qol. (1st January 2017) Authors: Gao, M.; Shi, W.; li, N.; li, M.; Wang, R.; J, X.; Wang, L.; Liu, X.; Sun, J.; Zhou, L.; Yang, J.; Zhang, Z.; Shi, J. Journal: Journal of sexual medicine Issue: Volume 14(2017)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1.4 GHz femtosecond comb generation by Fabry‐Pérot filtering of optical parametric oscillator frequency comb. Issue 13 (1st June 2013) Authors: Ferreiro, T.I.; Lamour, T.P.; Sun, J.; Reid, D.T. Journal: Electronics letters Issue: Volume 49:Issue 13(2013) Page Start: 833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 130 Vas Clip by 3D Printing Use in Vas Deferens Obstruction Animal Model Studies. (1st January 2017) Authors: Gao, M.; Ji, X.; Wang, L.; liu, X.; Sun, J.; Zhang, Z.; Zhou, L.; Yang, J.; Shi, J. Journal: Journal of sexual medicine Issue: Volume 14(2017)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 145P Preliminary results of a phase Ⅱ study of fruquintinib combined with sintilimab and chemotherapy as the first-line treatment in advanced naive EGFR- and ALK-negative non-squamous non-small cell lung cancer (nsq-NSCLC). (December 2022) Authors: Shu, Y.; Ma, P.; Shen, H.; Gao, W.; Chen, X.; Sun, J.; Xu, L. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 185. Disassociation mechanism of progenitor complex of botulinum neurotoxin serotype E. (January 2015) Authors: Swaminathan, Subramanyam; Eswaramoorthy, S.; Sun, J.; Li, H.; Singh, B.R. Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2701 Quantification of genomic loss of heterozygosity enables prospective selection of ovarian cancer patients who may derive benefit from the PARP inhibitor rucaparib. (September 2015) Authors: Lin, K.; Sun, J.; Maloney, L.; Goble, S.; Oza, A.; Coleman, R.; Scott, C.; Robillard, L.; Mann, E.; Isaacson, J.; Harding, T.; Giordano, H.; Rolfe, L.; McNeish, I.; Swisher, E.; Yelensky, R.; Allen, A.; Raponi, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2B.06: EPIGALLOCATECHIN-3-GALLATE ATTENUATES URIC ACID-INDUCED INFLAMMATORY RESPONSES AND OXIDATIVE STRESS BY MODULATING NOTCH PATHWAY. (June 2015) Authors: Xie, H.; Sun, J.; Chen, Y.; Zong, M.; Li, S.; Wang, Y. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 435 Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. (September 2015) Authors: Hodgson, D.R.; Dougherty, B.; Lai, Z.; Grinsted, L.; Spencer, S.; O'Connor, M.J.; Ho, T.W.; Robertson, J.D.; Lanchbury, J.; Timms, K.; Gutin, A.; Orr, M.; Jones, H.; Gilks, B.; Womack, C.; Sun, J.; Yelensky, R.; Gourley, C.; Ledermann, J.; Barrett, J.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 86P Efficacy and safety of IBI110 (anti-LAG-3 mAb) in combination with sintilimab (anti-PD-1 mAb) in advanced squamous non-small cell lung cancer (sqNSCLC): Updated results of the phase Ib study. (December 2022) Authors: Zhou, C.; Xu, N.; A. Xiong, ; Li, W.; Wang, L.; Wu, F.; Yu, J.; Mao, C.; Qian, J.; Zheng, Y.; Jiang, H.; Gao, Y.; Xiao, C.; Wang, W.; Zhuang, W.; Yang, J.; Sun, J.; Wang, H.; Chen, Y. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗